Patient
SITE012-0110
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE012 (BRA) (Dr. Kowalski)
consented 2026-01-05
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 1
moderate
assessed
2026-03-24
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-09-17 (study day 60); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.